Go to the list of all blogs
Allana's Avatar
published in Blogs
Mar 29, 2023
Top 5 AI Robots of the Month with + 20% returns

Top 5 AI Robots of the Month with + 20% returns

Tickeron is proud to announce the top-performing robots that have outperformed the S&P 500 index in the last month, generating over 20% annualized returns. Our team of expert quants has developed proprietary artificial intelligence models to power these algorithms, ensuring maximum efficiency and quality in their signals. Each algorithm has undergone rigorous multi-level backtesting and extensive forward testing to provide you with the confidence you need to make informed investment decisions.

Swing Trader: Stocks from Financial Sector (TA&FA)

This AI Robot is for swing traders focused on trading stocks of companies from the financial sector. The trading algorithm is based on the analysis of the correlation between the direction of movement of main financial stocks and other stocks included in this sector.

The analysis of correlated (similar) stocks is one of the most popular methods for creating trading strategies used by hedge funds. In the process of creating this robot, our team of quants conducted multi-level backtests on a larger amount of historical data. This allowed us to identify correlations relationships between the leaders of the sector and the rest of the stocks included in it. At the next step, we created an efficient mechanism for finding optimal points for opening positions using a pool of our proven algorithms.

Click to view full description and closed trades for free!

Day Trader: High Volatility Stocks for Active Trading (TA&FA)

This AI Robot is most suitable for active day traders who prefer to trade stocks with high volatility, but do not want to get a strong drawdown during a downtrend. To avoid this, we use a pool of technical indicators focused on finding uptrend reversal points, which allows us to balance short and long positions and prevent long drawdowns.

This robot is most suitable for active traders who have enough time to track 40-50 trades at the same time. The average duration of a transaction is 1 day, which allows our users to effectively use their capital and not get stuck in a trade for a long time.

Click to view full description and closed trades for free!

Swing Trader, Popular Stocks: Trading Like a Pro (TA&FA)

Introducing our AI Robot, designed for traders who aspire to trade like large hedge funds. Our team of quants has developed a unique algorithm that predicts price trends and potential reversal points for the 200 most active stocks on the US stock market. Through our rigorous testing process, we have consistently achieved an annualized return of 25% with this algorithm.

With a maximum of 100 simultaneous open trades and an average of 30 to 50, our robot ensures maximum independence of trading results from any one particular stock, providing you with a diversified set of open positions every day. Plus, with an average trade duration of 2 days, our robot has plenty of time to follow signals and generate profits.

Click to view full description and closed trades for free!

Day Trader, Popular Stocks: Short Bias Strategy (TA&FA)

This AI Robot is for traders who prefer to trade popular stocks with good liquidity and low spreads and are focused on taking mostly short positions. This strategy uses a combination of several algorithms to search for upcoming uptrend reversal points, which makes it effective in situations of market instability.

To increase profitability and accuracy of opening and closing trades, the algorithm uses different approaches to long and short positions. After entering the long trade, the robot places a fixed order "Take profit" at the level of 4% and a fixed order "Stop Loss" at the level of 3% of the position opening price. Also, the robot places a flexible trailing stop, which allows the robot to keep most of the profit in case of a market reversal. After entering the long trade, the robot places a fixed orders "Take profit" at the level of 3% and "Stop Loss" at the level of 2% of the position opening price.

Click to view full description and closed trades for free!

Swing Trader: Medium Volatility Stocks for Active Trading (TA&FA)

This particular AI robot is well-suited for traders who prefer to trade stocks with medium volatility but want to avoid significant drawdowns during downtrends. To achieve this, the robot employs a pool of technical indicators focused on identifying uptrend reversal points, which allows for a balanced approach to short and long positions and helps to prevent prolonged drawdowns.

The robot uses a proprietary method developed by our team of quants to evaluate the strength and quality of momentum of the most active stocks in the US stock market to select stocks. A complex algorithm, including a pool of technical indicators processed using neural networks, determines the entry points to positions.

Click to view full description and closed trades for free!

Get ahead of the game with our AI Robots - your ticket to success in the stock market!


Contributor

Allana's AvatarAllana|Expert

Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.


Interact to see
Advertisement
UBXG stock surged +79% over the last 30 days, driven by heightened trading volume and positive market sentiment amid broader technology sector trends. Over the past quarter, the stock rose +61%, reflecting recovery from earlier lows near its 52-week bottom.
CVGI stock surged approximately +89% over the last 30 days, driven by strong Q4 2025 earnings beat on revenue and positive 2026 guidance. Over the past quarter, shares rose about +126%, reflecting improved profitability, debt reduction, and a key partnership announcement.
SAFX stock surged +104% over the past 30 days, driven by positive updates on a $10 million capital raise and merger progress. Over the past quarter, the stock rose +44%, reflecting recovery from lows amid renewable energy sector interest and strategic developments.
LONA stock surged +80% over the past 30 days, driven by positive analyst upgrades, executive appointments, and full-year financial updates highlighting pipeline progress. Over the past quarter, shares rose +48%, reflecting improved investor sentiment in biotech amid clinical advancements.
Lifetime Brands (LCUT) stock surged +77% over the last 30 days, driven by a strong Q4 earnings beat and a Zacks Rank #1 (Strong Buy) upgrade that reflects an improved earnings outlook. Over the past quarter, shares rose +48%, supported by profitability gains despite softer sales, with adjusted EBITDA reaching $50.8 million for full-year 2025.
CURV stock surged approximately +73% over the last 30 days, driven primarily by a positive reaction to Q4 and fiscal 2025 earnings that beat expectations on EPS and revenue. Over the past quarter, the stock is up around +55%, reflecting recovery from lows near $1 amid ongoing store optimization and sub-brand launches
Blaize Holdings, Inc. (BZAI) focuses on artificial intelligence (AI)-enabled edge computing solutions, offering programmable AI processors and platforms for verticals such as smart cities, defense, retail, and enterprise markets. The company's core revolves around hardware like the Graph Streaming Processor (GSP) AI accelerator, compute cards, and software tools including Blaize AI Studio—a no-code/low-code environment for deploying AI models without source code expertise. Based in El Dorado Hills, California, and founded in 2010, it went public through a merger in early 2025.
Comstock Holding Companies, Inc. (CHCI) operates as an asset manager, developer, and operator of mixed-use and transit-oriented properties, mainly in the greater Washington, D.C. metropolitan area. The company targets high-growth urban and suburban markets, overseeing a portfolio that spans residential, commercial, hospitality, and parking assets near key metro stations. Its asset-light, fee-based model delivers recurring revenue through property management, leasing, development services, and asset recapitalization for institutional investors, family offices, and governments.
ARM stock surged +26% over the past 30 days, driven by announcements of in-house chip production and strong analyst upgrades amid AI enthusiasm. Over the past quarter, the stock climbed +38%, reflecting robust Q3 earnings beat with 26% revenue growth and data center royalty doubling.
Sable Offshore Corp. (SOC) is an independent oil and gas company focused on offshore operations in federal waters off California. The company owns and operates three platforms in the Santa Ynez Unit (SYU), spanning 16 federal leases across approximately 76,000 acres, along with subsea pipelines for crude oil, natural gas, and produced water transport to onshore facilities. Its core business model centers on restarting and developing prolific fields like the SYU, which had been idle due to regulatory and legal hurdles following a 2015 pipeline spill.
From what I see, Cheniere Energy Partners (CQP) holds a commanding position through its ownership and operation of the Sabine Pass LNG terminal in Louisiana, the largest LNG production facility in the U.S. with approximately 30 million tonnes per annum (mtpa) capacity across six trains, alongside the connected Creole Trail Pipeline. This setup makes CQP a leader in U.S. LNG exports, which have accounted for about 11% of global supply in recent years. The company's ~80% contracted production through long-term sale and purchase agreements (SPAs) provides revenue stability, with weighted average remaining lives of around 13 years.
In my view, Regeneron Pharmaceuticals holds a strong leadership position in biotechnology, thanks to its proprietary VelociSuite technologies, including VelocImmune for fully human antibody discovery. This enables a robust pipeline across immunology, oncology, ophthalmology, and rare diseases. The company's integrated model—from discovery to commercialization—drives high R&D productivity, with approximately 45 clinical programs and key partnerships like Sanofi for Dupixent and Bayer for EYLEA.
As I review argenx SE's place in the market, its strong footing in immunology stands out. This commercial-stage biopharmaceutical company focuses on differentiated antibody therapies for severe autoimmune diseases. The flagship product, VYVGART (efgartigimod), a first-in-class neonatal Fc receptor (FcRn) inhibitor, has secured leadership in generalized myasthenia gravis (gMG) and chronic inflammatory demyelinating polyneuropathy (CIDP), with approvals across the U.S., Europe, and Japan. The Immunology Innovation Program (IIP) fuels a robust pipeline, featuring next-generation FcRn candidates like ARGX-213 and ARGX-124, alongside first-in-class assets such as empasiprubart (C2 inhibitor, ARGX-117) and adimanebart (MuSK agonist).
I've long admired Alnylam Pharmaceuticals as the pioneer in RNA interference (RNAi) therapeutics, a gene-silencing technology that has delivered six approved products, including AMVUTTRA (vutrisiran), ONPATTRO (patisiran), GIVLAARI (givosiran), and OXLUMO (lumasiran). The company's proprietary platform, enhanced by GalNAc conjugation for liver targeting and emerging extra-hepatic delivery innovations, creates a solid competitive moat in precision genetic medicines.
As I review BeOne Medicines AG's position in the oncology space, what stands out is its role as a global leader with a diversified portfolio that includes both commercial-stage therapies and a deep pipeline targeting hematologic and solid tumors. The flagship product, BRUKINSA (zanubrutinib), a Bruton's Tyrosine Kinase (BTK) inhibitor, has secured approvals in over 75 markets, solidifying its dominance in chronic lymphocytic leukemia (CLL) and other blood cancers. This is complemented by TEVIMBRA (tislelizumab), an anti-PD-1 antibody approved in more than 50 markets for various indications, which broadens its reach in immunotherapy.
Rio Tinto holds a premier position as one of the world's largest mining companies, anchored by low-cost, Tier 1 assets. Its Pilbara iron ore operations in Australia deliver industry-leading margins, thanks to integrated rail and port infrastructure that gives it a structural cost advantage over higher-cost producers. In copper, the company has significant stakes in Escondida, the world's largest copper mine, and full ownership of Oyu Tolgoi in Mongolia, setting it up well to benefit from tightening supply as demand surges for electrification and renewables.
I've always been impressed by how Visa (V) commands the global payments landscape. As an open-loop network, it connects issuers, acquirers, merchants, and consumers without issuing cards or extending credit itself. The VisaNet platform processes over 65,000 transactions per second across more than 200 countries, supporting a ~52% share of the global credit card market and ~60% of debit. This scale generates powerful network effects, where greater adoption benefits everyone involved and creates formidable barriers to entry.
Following the Kenvue consumer health spin-off, Johnson & Johnson has transformed into a focused healthcare leader, emphasizing Innovative Medicine (pharmaceuticals) and MedTech (devices). In my view, this repositioning sharpens the company's edge in high-margin areas such as oncology, immunology, neuroscience, cardiovascular, surgery, and vision, where its diversified portfolio and R&D efficiency provide clear competitive advantages.
I've long appreciated ASML Holding N.V.'s dominant position in the semiconductor lithography market. The company commands over 90% share in advanced deep ultraviolet (DUV) immersion systems and 100% in EUV lithography—the critical technology for chips below 7nm nodes used in AI, high-performance computing, and memory. This near-monopoly comes from decades of R&D investment, exclusive partnerships like Zeiss for optics, and a vast installed base that generates steady service revenue. From what I see, competitors such as Nikon and Canon remain far behind in EUV, sticking to mature nodes.
I've been watching Micron Technology (MU) closely through its recent volatility, which mirrors the semiconductor sector's heightened sensitivity to AI demand and supply constraints. The stock saw a sharp post-earnings sell-off tied to elevated capital expenditure plans, yet it has rebounded with surging DRAM prices—up 90-95%—and memory suppliers booked out for years. From what I see, broader tech optimism, including key partnerships and persistent supply tightness, is driving upward momentum. This positions MU as a pivotal player in high-bandwidth memory (HBM) for data centers. Trading near recent highs around $368, the shares highlight investor focus on Micron's critical role in the AI infrastructure expansion under these constrained industry conditions.